Aclaris Therapeutics Inc (ACRS)
R&D Expense Growth
20.39%
Quarterly · Period ending:
ACRS R&D Expense Growth
Latest reported20.39%period ending
Latest reported20.39%period ending
ACRS Quarterly R&D Growth (QoQ) (0.00% → 20.39%)
Latest values, visible window
High-resolution chart · PNG
ACRS r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 20.3934% | |
| -5.5897% | |
| 27.2951% | |
| 13.7916% | |
| -1.1654% | |
| 28.3404% | |
| 51.5447% | |
| -32.0014% | |
| -11.031% | |
| -63.0526% | |
| 11.6016% | |
| -5.5351% | |
| 11.9007% | |
| 7.1896% | |
| -10.9232% | |
| 25.9705% | |
| 31.2666% | |
| 1.4466% | |
| 0.9015% | |
| 76.9786% | |
| 0.7527% | |
| -12.4735% | |
| 43.5096% | |
| -3.4952% | |
| -15.7744% | |
| -33.6187% | |
| -28.5361% | |
| -8.1659% | |
| -11.5317% | |
| 1.9553% | |
| 22.6351% | |
| 13.9231% | |
| 2.7782% | |
| 3.1617% | |
| 21.401% | |
| 36.3967% | |
| 2.4833% | |
| 11.9401% | |
| -3.0578% | |
| -27.1858% | |
| 3.1568% | |
| 296.9609% | |
| -74.4685% | |
| 424.7072% | |
| 3.2239% | |
| -15.4333% | |
| -2.0505% | |
| 78.0136% | |
| 0% | |
| 0% |